Discontinuation of Low-Dose Levothyroxine in Older Adults With Subclinical Hypothyroidism
A legfontosabb adatok
- Ki végzi
- Spyridoula Maraka
- Hol
- Gainesville, Little Rock és Rochester (Egyesült Államok)Mind a 3 helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Fázis
- 4. fázis
- Résztvevők
- 138 fő, tervezett
- Kezdés
- 2027. okt.
- Várható befejezés
- 2031. szept.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Levothyroxine Pill
- Placebo
- A regiszteradat frissítve
- 2026. augusztus 26.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults aged 65 or older who take low-dose levothyroxine for subclinical hypothyroidism (a mildly underactive thyroid). It tests whether stopping the drug is safe, compared with continuing it.
- Életkor
- 65 years or older
- Nem
- All sexes
- A betegség stádiuma
- Subclinical hypothyroidism: before treatment, TSH was above the normal range but <10 mIU/L, with normal fT4. Thyroid tests (TSH and fT4) must now be in the normal range.
- Korábbi kezelés
- Must have taken levothyroxine for subclinical hypothyroidism for at least 6 months. Dose must be ≤50 mcg/day, or ≤25 mcg/day if weighing <50 kg (110 lb). Must have had outpatient care at the study site for at least 12 months.
- Biomarker vagy leletérték
- TSH and fT4 within the normal range at enrolment. TSH never >10 mIU/L in the health record.
A részvétel fő kizáró okai
- Taking drugs that affect thyroid hormones, such as antithyroid drugs, amiodarone or lithium
- Past thyroid cancer, goiter pressing on the neck, thyroid surgery or radioactive iodine therapy
- NYHA Class IV heart failure, or a hospital stay for major illness or surgery in the last 4 weeks
- LDL cholesterol >190 mg/dL (4,9 mmol/L)
- Untreated depression, uncontrolled mental illness, chronic fatigue syndrome or pain, or life expectancy under 6 months
A regiszter feltételei, szó szerint
Mind a 21 feltétel megnézéseKevesebb
Ki vehet részt
- Age ≥65 years
- Euthyroid at the time of enrollment, defined as thyroid-stimulating hormone (TSH) and free thyroxine (fT4) levels within the reference range
- Receiving levothyroxine treatment for subclinical hypothyroidism for at least 6 months
- Receiving levothyroxine at a dose ≤50 mcg/day, or ≤25 mcg/day for participants weighing <50 kg
- Receiving outpatient care at the participating study site for at least 12 months; Subclinical hypothyroidism is defined as a TSH level above the normal reference range but <10 mIU/L, with a normal fT4 level, prior to initiation of levothyroxine therapy
Ki nem vehet részt
- Levothyroxine therapy initiated less than 6 months before enrollment
- Current use of medications that affect thyroid hormone levels, such as antithyroid medications, amiodarone, or lithium
- Hospitalization for a major illness or elective surgery within the previous 4 weeks, including acute coronary syndrome, acute myocarditis, pancarditis, or stroke
- History of thyroid cancer or goiter with compressive symptoms
- History of partial or total thyroidectomy or radioactive iodine therapy
- New York Heart Association (NYHA) Class IV heart failure
- Unstable medical condition that, in the investigator's judgment, would jeopardize participant safety or interfere with study participation
- Terminal illness with a life expectancy of less than 6 months
- Uncontrolled psychiatric disorder
- Uncontrolled chronic fatigue syndrome
- Severe dyslipidemia, defined as LDL cholesterol >190 mg/dL
- TSH >10 mIU/L at any time documented in the institutional electronic health record
- Abnormal thyroid function at the time of enrollment
- Lack of decision-making capacity
- Untreated depression
- Uncontrolled pain
Helyszínek itt: Egyesült Államok
- University of Florida Clinical Research CenterGainesville, Egyesült ÁllamokContact: Naykky Singh Ospina, M.D., M.S.Toborzás még nem indult
- Central Arkansas Veterans Healthcare SystemLittle Rock, Egyesült ÁllamokContact: Spyridoula Maraka, M.D., M.S.Toborzás még nem indult
- Mayo ClinicRochester, Egyesült ÁllamokContact: Juan Pablo Brito Campana, M.B.B.S.Toborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to learn whether low-dose levothyroxine can be safely discontinued in adults aged 65 years or older who are taking levothyroxine for subclinical hypothyroidism. The study will also evaluate the cost-effectiveness of discontinuing levothyroxine.
A teljes eredeti leírásKevesebb
The main questions it aims to answer are:
* Does discontinuing levothyroxine result in no clinically meaningful worsening of thyroid-related symptoms compared with continuing levothyroxine? * What are the effects of discontinuing levothyroxine on quality of life, tiredness, cognition, thyroid hormone levels, lipid levels, weight, and adverse events? * Is discontinuing levothyroxine cost-effective compared with continuing treatment?
Researchers will compare participants who discontinue levothyroxine and receive placebo with participants who continue their current dose of levothyroxine to determine the effects of levothyroxine discontinuation.
Participants will:
* Complete a 2-week run-in period during which they continue their usual levothyroxine and record their medication use. * Eligible participants will be randomly assigned to either continue their current dose of levothyroxine or receive a matching placebo for 6 months. Participants, their clinicians, and study investigators will not know which treatment they are receiving during the study. * Complete study assessments at baseline, approximately 2 months, and 6 months. Assessments will include blood tests, measurements such as body weight, questionnaires about thyroid-related symptoms and quality of life, and assessments of cognition and other health outcomes.
A vizsgálat 2 csoportja
- Levothyroxine ContinuationMár használt kezelés, összehasonlításként
Participants will continue their pre-study dose of levothyroxine for 6 months using blinded study medication.
Kezelés: Levothyroxine Pill
- Levothyroxine DiscontinuationA vizsgált kezelés
Participants will discontinue levothyroxine and receive matching placebo for 6 months using blinded study medication.
Kezelés: Placebo
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Discontinuation of Low Dose Levothyroxine Therapy for Older Adults With Subclinical Hypothyroidism: a Randomized, Double-blinded, Placebo-controlled Study
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. augusztus 26.